These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28743581)

  • 1. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
    Wang CC; Zhang M; Li H; Li XL; Yue LT; Zhang P; Liu RT; Chen H; Li YB; Duan RS
    Neurosci Lett; 2017 Aug; 656():169-176. PubMed ID: 28743581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.
    Wang CC; Li H; Zhang M; Li XL; Yue LT; Zhang P; Zhao Y; Wang S; Duan RN; Li YB; Duan RS
    J Neuroinflammation; 2015 Jun; 12():118. PubMed ID: 26071315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
    Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
    Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.
    Huang H; Ran H; Liu X; Yu L; Qiu L; Lin Z; Ou C; Lu Y; Yang W; Liu W
    Int Immunopharmacol; 2021 Apr; 93():107434. PubMed ID: 33556668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis.
    Li H; Wang CC; Zhang M; Li XL; Zhang P; Yue LT; Miao S; Wang S; Liu Y; Li YB; Duan RS
    Mol Cell Neurosci; 2015 Sep; 68():284-92. PubMed ID: 26311508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
    Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
    Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response.
    Liu RT; Zhang P; Yang CL; Pang Y; Zhang M; Zhang N; Yue LT; Li XL; Li H; Duan RS
    J Neuroimmunol; 2017 Oct; 311():71-78. PubMed ID: 28844501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
    Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
    J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis.
    Zhang P; Yang CL; Liu RT; Li H; Zhang M; Zhang N; Yue LT; Wang CC; Dou YC; Duan RS
    Mol Immunol; 2018 Feb; 94():200-208. PubMed ID: 29331804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway.
    Lu Y; Ma Q; Yu L; Huang H; Liu X; Chen P; Ran H; Liu W
    Int Immunopharmacol; 2023 Feb; 115():109693. PubMed ID: 36638660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
    Xin N; Fu L; Shao Z; Guo M; Zhang X; Zhang Y; Dou C; Zheng S; Shen X; Yao Y; Wang J; Wang J; Cui G; Liu Y; Geng D; Xiao C; Zhang Z; Dong R
    Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.
    Yao X; Kong Q; Xie X; Wang J; Li N; Liu Y; Sun B; Li Y; Wang G; Li W; Qu S; Zhao H; Wang D; Liu X; Zhang Y; Mu L; Li H
    Immunology; 2014 Nov; 143(3):396-405. PubMed ID: 24850614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting HIF-1α alleviates the inflammatory responses and rebuilds the CD4
    Yu L; Ran H; Lu Y; Ma Q; Huang H; Liu W
    Life Sci; 2024 Jan; 336():122287. PubMed ID: 37995933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
    Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
    Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4
    Li Y; Shan Y; Xu L; Chen W; Li Y
    Int Immunopharmacol; 2024 Sep; 139():112699. PubMed ID: 39024745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.